CENTRAL LABORATORIES FEATURED ARTICLES
CENTRAL LABORATORIES WHITE PAPERS & ARTICLES
-
Everything Clinical Trial Leaders Need To Know About AI Agents
A practical guide to what agentic AI actually means for clinical trials, from ontologies and human-in-the-loop governance to continuous validation and the build-versus-buy decision.
-
How Clinical Trials Are Moving From Digitized To Agentified
See how generative and agentic AI can streamline clinical trials, with independent analysis modeling up to $21M in value and 82x ROI for agent-enabled monitoring.
-
What Is A Forward Deployed Engineer, And Why Do Clinical Trials Need One?
See how this model can compress traditional software development from a year or more into months, including a real example of an agent built to automatically detect CTMS milestone errors and anomalies.
-
Combining Multiple Challenge Models Within A Single Individual
Pairing immune challenges in healthy volunteers tests whether pharmacology is consistent across cells, tissue, and systemic responses before patient trials.
-
What Most Psychiatric Drug Development Programmes Learn Too Late
Clinical phase completion doesn’t end uncertainty. Six key questions on brain exposure, pharmacology, therapeutic window, and patient variability can reveal whether the molecule failed, or the mechanism.
CENTRAL LABORATORIES APPLICATIONS & STUDIES
-
Stabilizing A Biotech Sponsor's Data Management And Biostatistics Functions8/29/2026
Discover how a rapid mid-study data transition rescued an endangered clinical trial, cleaned up compromised data, and secured a critical interim database lock within twelve months.
-
Driving ROI: A Real-Time Clinical Trial Oversight Solution8/3/2026
Sample errors, delays, and query overload drain clinical trial budgets. Learn how real-time data capture can shorten timelines and protect data quality.
-
Accelerating A Schizophrenia Trial While Ensuring Quality7/31/2026
Tight timelines and rising patient targets don't have to derail a trial. See how speed and data quality can work together from enrollment to database lock.
-
Reserving Data Integrity With Retrospective Manual Entry7/5/2026
A look at implementing randomization mid-trial by reconstructing subject and inventory records without disrupting sites or compromising data integrity.
-
A Mission To Expand Recruitment Territory6/11/2026
Learn how a proactive feasibility approach helps sponsors strengthen enrollment forecasting, mitigate risk, and implement timely interventions that improve study execution and clinical development.
CENTRAL LABORATORIES SOLUTIONS
- De-Risk Randomization With The Endpoint Biostatistical Approach
- RWD Solutions
- Connect Your Clinical Vision To Reality With Trusted AI
- Managing Execution Of A Phase III Clinical Trial
- Measuring A Wide Range Of CNS Effects In A Pharmacological Context
- Driving Success In Dermatology Drug Development
- From Raw Data To Real Insight
- Accelerate Post-Approval Research By Streamlining the Entire Study Lifecycle
- Benefit For An AI-Automated Extraction Model
- Citeline's Pharmaprojects & Biomedtracker Solution
VIDEOS
NEWS
- Quotient Sciences Proprietary AI-Enhanced Solution Optimizes Formulation In Clinical Study
- Avance Clinical Appoints Inaugural Chief Commercial Officer, Reinforcing Global Growth Strategy
- Ypsomed Opens Production Site In China
- Ypsomed Launches YpsoLoop As The First Autoinjector Platform Designed For Circularity
- Ypsomed Expands Offering For Clinical Studies
- Ypsomed Receives The Red Dot Design Award 2026 For YpsoLoop
- Ypsomed Receives FDA Clearance For SmartPilot
- Signant Health Acquires Ametris To Create An End-To-End eCOA And Wearables Platform
- Avance Clinical Announces Asia Pacific And Mainland China Expansion Ahead Of BIO International Convention 2026
- The Ottawa Hospital's Biotherapeutics Manufacturing Centre (BMC) Makes Breakthroughs Break Through As Boreal Biomanufacturing
- Suvoda Patient App Earns "Best Patient Relationship Management Solution" In 2026 MedTech Breakthrough Awards Program
- Quotient Sciences Advances AI-Designed Drug Product Into Clinical Development
- Paradigm Health Announces Collaboration With The FDA To Transform Regulatory Review Of Clinical Trial Data
- Inside Information: Nanoform Signs First Exclusivity Agreement For Ultra-High Concentration Subcutaneous Delivery
- Suvoda Announces Agentic RTSM, Enabling The Reduction Of Clinical Trial Startup Timelines By Up To 80%
- Signant Health Enters Definitive Agreement To Acquire Ametris
- Crucial Data Solutions Expands TrialKit AI With Study Simulation And Validation Capabilities
- AI HealthTech Pioneer Biorce Opens U.S. Offices In Austin To Accelerate Global Expansion
- Signant Health Appoints Specialist Physician And Clinical Research Expert Dr. Graham C. Ellis As Clinical Vice President To Strengthen Metabolic Disease And Diabetes Trial Capabilities
- Suvoda Advances Clinical Trial Financial Planning With Support For Complex Multi-Payee Budgets
- Suvoda Named "Most Innovative Clinical Trial Technology Firm Of 2026"
- Avance Clinical Appoints Liahna Toy To Lead Global Early Phase Center Of Excellence
- Avance Clinical Strengthens Global Oncology Offering With Acquisition Of U.S-Based LumaBridge
- Health Equity Research Goes Global—Without Waiting For Perfect Data
- International Study Confirms Universal Digital Health Framework
- ISPOR Announces New Executive Director
- Quotient Sciences Extends Commercial Manufacturing Partnership For Ultra-Rare Disease Treatment
- Sygnature Discovery Unveils Strategic Rebrand To Cement Status As A Global Drug Discovery Partner
- Suvoda Sets New Standard For Streamlined Patient And Site Experience In Clinical Trials
- Suvoda IRT Named A Leader In Everest Group's RTSM PEAK Matrix®